We are live on !
Find out more
JW Asset Management Portfolio holdings
AUM
$320M
Turnover
33.33%
1-Year Est. Return
140.1%
This Fund
S&P 500
This Quarter Est. Return
+63.25%
1 Year Est. Return
+140.1%
3 Year Est. Return
+250.82%
5 Year Est. Return
+197.91%
10 Year Est. Return
+3,970.05%
AUM
$320M
AUM Growth
+$76.4M
(+31%)
Cap. Flow
-$34.8M
Cap. Flow % of AUM
Cap. Flow %
-10.88%
Top 10 Holdings %
Top 10 Hldgs %
95.6%
Holding
24
New
5
Increased
2
Reduced
6
Closed
3
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$1.87M |
| 2 |
Travere Therapeutics
TVTX
|
+$1.33M |
| 3 |
Dell
DELL
|
+$1.01M |
| 4 |
Ligand Pharmaceuticals
LGND
|
+$943K |
| 5 |
TRLV
Trulieve Cannabis Corp
TRLV
|
+$808K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Establishment Labs
ESTA
|
+$26.5M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$7.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$4.98M |
| 4 |
Iris Energy
IREN
|
+$1.04M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$577K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 78.07% |
| 2 | Technology | 9.8% |
| 3 | Consumer Staples | 4.52% |
| 4 | Consumer Discretionary | 3.85% |
| 5 | Financials | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Establishment Labs
ESTA
$2B
| $231M | 72.24% |
2,692,856
-368,838
| -12% | -$26.5M |
2018 Q3
31 quarters
|
|
|
2
Sandisk
SNDK
$189B
| $17.8M | 5.55% |
7,810
+1,310
| +20% | +$1.87M |
2026 Q1
1 quarter
|
|
3
Vita Coco
COCO
$3.12B
| $14.5M | 4.52% |
218,621
| – | – |
2023 Q3
11 quarters
|
|
4
DELISTED
Catalyst Pharmaceutical
CPRX
| $12.2M | 3.82% |
388,392
| – | – |
2022 Q4
14 quarters
|
|
5
Micron Technology
MU
$1.05T
| $8.08M | 2.53% |
7,000
| – | – |
2026 Q1
1 quarter
|
|
|
6
Iris Energy
IREN
$10.8B
| $6.61M | 2.07% |
144,650
-20,000
| -12% | -$1.04M |
2025 Q4
2 quarters
|
|
7
Idaho Strategic Resources
IDR
$327M
| $4.62M | 1.45% |
141,197
-2,000
| -1% | -$77.7K |
2022 Q1
17 quarters
|
|
8
Ralph Lauren
RL
$23.3B
| $4.01M | 1.25% |
10,000
| – | – |
2025 Q2
4 quarters
|
|
9
CAVA Group
CAVA
$6.06B
| $3.92M | 1.23% |
50,000
| – | – |
2025 Q1
5 quarters
|
|
10
NVIDIA
NVDA
$5.26T
| $3.05M | 0.95% |
15,250
| – | – |
2023 Q3
11 quarters
|
|
11
On Holding
ONON
$10.8B
| $2.58M | 0.81% |
72,950
-10,000
| -12% | -$366K |
2025 Q4
2 quarters
|
|
12
Five Below
FIVE
$12.7B
| $1.8M | 0.56% |
10,000
| – | – |
2024 Q3
7 quarters
|
|
|
13
Travere Therapeutics
TVTX
$4.8B
| $1.7M | 0.53% |
+30,000
| New | +$1.33M |
2026 Q2
0 quarters
|
|
14
Heron Therapeutics
HRTX
$57.2M
| $1.6M | 0.5% |
3,751,073
| – | – |
2023 Q2
12 quarters
|
|
|
15
Dell
DELL
$319B
| $1.51M | 0.47% |
+3,500
| New | +$1.01M |
2026 Q2
0 quarters
|
|
|
16
Ligand Pharmaceuticals
LGND
$6.21B
| $1.26M | 0.4% |
+4,000
| New | +$943K |
2026 Q2
0 quarters
|
|
17
Marvell Technology
MRVL
$219B
| $953K | 0.3% |
+3,200
| New | +$642K |
2026 Q2
0 quarters
|
|
|
TRLV
18
Trulieve Cannabis Corp
TRLV
$2.05B
| $824K | 0.26% |
+83,869
| New | +$808K |
2026 Q2
0 quarters
|
|
19
Liquidia Corp
LQDA
$4.07B
| $811K | 0.25% |
10,176
-6,000
| -37% | -$322K |
2025 Q3
3 quarters
|
|
20
AdvisorShares Pure US Cannabis ETF
MSOS
$749M
| $787K | 0.25% |
155,000
+75,000
| +94% | +$352K |
2025 Q4
2 quarters
|
|
21
High Tide
HITI
$238M
| $220K | 0.07% |
96,643
-5,501
| -5% | -$13.1K |
2023 Q3
11 quarters
|
|
|
22
Alphabet (Google) Class C
GOOG
$3.87T
| – | – |
-27,539
| Closed | -$7.9M | – |
|
|
23
Meta Platforms (Facebook)
META
$1.59T
| – | – |
-8,700
| Closed | -$4.98M | – |
|
|
24
Invesco QQQ Trust
QQQ
$487B
| – | – |
-1,000
| Closed | -$577K | – |
|
Similar funds
IP
LJCM
AFS
JW Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, JW Asset Management held 24 positions worth $320M, up 31% from $244M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
JW Asset Management withdrew a net $34.8M in Q2 2026, closing 3 positions and reducing 6 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $7.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 77% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, JW Asset Management opened a new position in Travere Therapeutics worth $1.7M.
- JW Asset Management's largest Q2 2026 buy was Travere Therapeutics: 30,000 shares worth $1.7M.
- JW Asset Management added most to Sandisk in Q2 2026, an estimated $1.87M increase.
- JW Asset Management's biggest Q2 2026 reduction was Establishment Labs, cutting an estimated $26.5M.
- JW Asset Management fully exited Alphabet (Google) Class C in Q2 2026, selling an estimated $7.9M.
- JW Asset Management's ten largest holdings make up 96% of its $320M portfolio in Q2 2026.
- JW Asset Management opened 5 new positions and closed 3 in Q2 2026.
- JW Asset Management's portfolio value rose 31% quarter-over-quarter to $320M.
Based on JW Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.